STAT3 and diabetic kidney disease: Diabetic mice receiving JAK1 and JAK2 inhibitors showed that this treatment downregulates the expression of STAT3-dependent genes, such as Notch1, TGF-β, and CCR2, which are the driving factors of DKD (Zhang et al., 2017).